Taipei: Over 40,000 people sought medical treatment for COVID-19 in Taiwan last week, marking more than double the previous week’s figure and the seventh consecutive weekly increase, as reported by the Centers for Disease Control (CDC) on Tuesday.
According to Focus Taiwan, CDC’s Epidemic Intelligence Center Deputy Director Lee Chia-lin highlighted the rapid rise of the current outbreak, noting an increase in severe and fatal cases at a regular news briefing in Taipei. CDC data revealed a total of 41,402 outpatient and emergency visits related to COVID-19 from May 18-24, a significant increase from the 19,097 recorded the prior week.
The seventh consecutive weekly increase surpassed the 23,555 visits reported during the same period in 2024. CDC spokesperson Lo Yi-chun indicated that while increased testing amid the outbreak may have exposed previously undetected cases, the surge is primarily driven by the rapid spread of the virus. The new variant NB.1.8.1 is noted for its immune evasion capabilities and higher transmissibility compared to previously dominant variants.
Lo also pointed out that the lack of a major outbreak during the winter left a significant portion of the population without immunity from natural infection. The CDC had initially estimated the current COVID-19 outbreak would peak in mid to late June, with weekly medical visits reaching up to 100,000. However, Lo now projects the peak will be delayed until late June or early July, with weekly visits expected to reach between 150,000 and 200,000.
Lo advised the public to wear masks in medical and long-term care facilities, on public transportation, and in crowded indoor spaces, especially for the elderly and those with chronic illnesses. Individuals with fever or respiratory symptoms are encouraged to stay at home and wear masks if leaving home is necessary.
In response to the surge, the Taiwan Food and Drug Administration (TFDA) announced on Monday an increase in the production of COVID-19 rapid test kits, with the weekly supply exceeding twice the CDC’s estimated needs. According to the TFDA, local manufacturers are expected to produce 460,000 kits this week and 620,000 kits next week.
The TFDA emphasized its ongoing efforts to ensure timely restocking of rapid test kits by reaching out to domestic pharmacy and convenience store chains and held a meeting with stakeholders on Monday to address distribution and stock expansion across Taiwan.